Last year, shares of healthcare company CVS Health ( CVS 1.92%) crashed by more than 43%. The company struggled with rising ...

CVS director Mike Mahoney, whose day job is CEO of Boston Scientific, bought 30,000 shares of the healthcare company.

Earnings have fallen but are still strong enough to meet CVS Health's dividend commitment. Management expects adjusted ...

CVS sees 23% revenue growth in healthcare benefits & projects 10% EPS in 2025, with Aetna recovery boosting performance.

For the second day in a row, CVS Health's (NYSE: CVS) stock price saw a satisfying jump on Thursday. It closed the day almost 5% higher, on the back of both lingering optimism and news of another in a ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Stock prices used were the afternoon prices of Feb. 7, 2025. The video was published on Feb. 9, 2025. Should you invest $1,000 in CVS Health right now? Before you buy stock in CVS Health ...

The positive investor sentiment on CVS is due to the pharmacy chain operator's fourth-quarter earnings report, which were published early Wednesday morning. The company squeaked past the consensus ...

Learn More » Following that, a clutch of analysts wasted little time in raising their price targets on CVS stock -- in one case, even upgrading their recommendation. This was Leerink Partners ...

The stock (CVS) soared 15.2% toward a four-month in afternoon ... He said that PBMs have a "proven, unequivocal mechanism" to negotiate down the price of drugs for both consumers and payers.